Showing results (151-160 of 193) with videos related to

Sort By:
Pageof 20
European Journal of Haematology|April 4, 2020
Acute myeloid leukemia with inv(3)(q21.3q26.2)/t(3;3)(q21.3;q26.2): Study of 61 patients treated with intensive protocolsMarta Sitges, Blanca Boluda, Ana Garrido, et al.
Cancer|September 25, 2014
Prognostic factors for advanced-stage human immunodeficiency virus-associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: a multi-institutional retrospective studyJorge J Castillo, Mark Bower, Jérémy Brühlmann, et al.
Hemasphere|September 5, 2024
Human immunodeficiency virus-associated Lymphomas: EHA-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upKai Hübel, Mark Bower, Igor Aurer, et al.
Bone Marrow Transplantation|November 3, 2018
Hematopoietic stem cell transplantation for adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission: a position statement of the European Working Group for Adult Acute Lymphoblastic Leukemia (EWALL) and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)Sebastian Giebel, David I Marks, Nicolas Boissel, et al.
Genes, Chromosomes & Cancer|July 25, 2019
Molecular profiling refines minimal residual disease-based prognostic assessment in adults with Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemiaJordi Ribera, Lurdes Zamora, Mireia Morgades, et al.
Leukemia & Lymphoma|May 31, 2017
Frequency and prognostic significance of additional cytogenetic abnormalities to the Philadelphia chromosome in young and older adults with acute lymphoblastic leukemiaCristina Motlló, Josep-Maria Ribera, Mireia Morgades, et al.
ESMO Open|January 21, 2020
EHA evaluation of the ESMO-Magnitude of Clinical Benefit Scale version 1.1 (ESMO-MCBS v1.1) for haematological malignanciesBarbara Kiesewetter, Nathan I Cherny, Nicolas Boissel, et al.
European Journal of Haematology|February 22, 2023
Prognosis of patients with acute lymphoblastic leukaemia relapsing after allogeneic stem cell transplantationChristelle Ferra Coll, Mireia Morgades de la Fe, Laura Prieto García, et al.
Haematologica|February 12, 2002
Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trialJosep-Maria Ribera, Juan-José Ortega, Albert Oriol, et al.
Blood|September 10, 2013
Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patientsStefan K Barta, Xiaonan Xue, Dan Wang, et al.
Pageof 20